- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 1.11B sh |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $31.07B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $29.73B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $37.75B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $36.25B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2.54B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $3.69B |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 1.04B sh |
| Capex | Q1 2025 · Mar 31, 2024 | $31.98M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $738.25M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $5.83B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $5.23B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.02 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.08 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $145.24M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $130.92M |
| Net Income | Q1 2025 · Mar 31, 2024 | $88.04M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $100.06M |
| Revenue | Q1 2025 · Mar 31, 2024 | $115.61M |